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ABSTRACT
Trehalose is a disaccharide of two D-glucose molecules linked by a glycosidic linkage, which plays 
both structural and functional roles in bacteria. Trehalose can be synthesized and degraded by 
several pathways, and induction of trehalose biosynthesis is typically associated with exposure to 
abiotic stress. The ability of trehalose to protect against abiotic stress has been exploited to 
stabilize a range of bacterial vaccines. More recently, there has been interest in the role of this 
molecule in microbial virulence. There is now evidence that trehalose or trehalose derivatives play 
important roles in virulence of a diverse range of Gram-positive and Gram-negative pathogens of 
animals or plants. Trehalose and/or trehalose derivatives can play important roles in host coloni-
zation and growth in the host, and can modulate the interactions with host defense mechanisms. 
However, the roles are typically pathogen-specific. These findings suggest that trehalose meta-
bolism may be a target for novel pathogen-specific rather than broad spectrum interventions.
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Trehalose is a disaccharide of two D-glucose molecules 
linked by a glycosidic linkage. There are three possible 
structures of trehalose (α,β-1,1-, β,β-1,1-, and α,α1,1-) 
but the α,α-1,1-trehalose form is the predominant form 
found in living organisms[1]. The 1,1 linkage provides 
structural rigidity and consequently unique hydration 
properties [2]. Trehalose is produced by a wide variety 
of plants and algae, many invertebrates[1] and by 
microorganisms such as bacteria, yeasts, and fungi 
[3,4]. Mammals, including humans, do not have the 
ability to synthesis trehalose, though they can use exo-
genous trehalose as a carbon source.
Trehalose plays a wide range of functional and struc-
tural roles in organisms. In insects, trehalose is the 
major sugar in hemolymph, providing an instant 
source of energy, for example during flight [5]. 
Possibly the most dramatic evidence of trehalose- 
mediated resistance to stress is the desiccation response 
of the resurrection plant (Selaginella lepidophylla) [6]. 
Dried, and apparently dead plants, are able to recover 
when re-hydrated because of the ability of trehalose to 
protect molecules and cells from irreversible damage. 
What has become apparent more recently is that treha-
lose-6-phosphate can regulate metabolism, including 
the regulation of energy generating pathways and in 
plants the regulation of photosynthesis [7]. A previous 
review proposed that the loss of trehalose metabolism is 
associated with reduced pathogenicity [8], and there 
have been some important new findings in this field 
since 2013. This review considers the roles of trehalose 
in bacteria, and especially the interplay between treha-
lose biosynthesis, trehalose degradation, the regulation 
of metabolism and virulence, and the ways in which 
trehalose biology can be exploited to control disease.
Trehalose biosynthesis pathways
Trehalose can be synthesized by several pathways, and 
some organisms possess more than one biosynthetic 
pathway, reflecting the importance of this disaccharide. 
The most common is the TPS/TPP (also known as 
OtsBA) biosynthetic pathway. This pathway involves 
two enzymes, trehalose-6-phosphate synthase (TPS or 
OtsA) and trehalose-6-phosphate phosphatase (TPP or 
OtsB), to convert glucose-6-phosphate and UDP- 
glucose to trehalose (Figure 1). An alternative TreYZ 
pathway involves the production of trehalose from mal-
tooligosacharides by maltooligosyltrehalose synthase 
(TreY) and maltooligosyltrehalose trehalohydrolase 
(TreZ). The TreS biosynthetic pathway involves 
a single trehalose synthase (TreS) enzyme which is 
able to reversibly inter-convert trehalose and maltose. 
The TreP and TreT biosynthetic pathways are also 
reversible. The TreP pathway involves a trehalose phos-
phorylase enzyme (TreP). The TreT pathway generates 
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trehalose from ADP-glucose and glucose using treha-
lose glycosyltransferring synthase enzyme (TreT). All of 
these trehalose synthesis pathways are found in bac-
teria [9].
In E. coli [10], expression of otsBA is linked to RpoS, 
the master stress-response regulator [10]. However, 
exposure to a range of stresses can induce trehalose 
biosynthesis in an RpoS-independent manner. 
Classically trehalose biosynthesis is induced by hyper- 
osmotic stress or entry of bacterial cultures into the 
stationary phase [11]. Cold-shock can also induce tre-
halose synthesis by the otsBA system [12]. Exposure to 
ethanol or NaCl stress can induce trehalose biosynth-
esis in P. aeruginosa via the TreYZ pathway [13].
Trehalose import and degradative pathways
Alternative pathways exist for the import and degrada-
tion of trehalose by bacteria (Figure 1). Trehalose may 
enter the cell either via a permease and then be hydro-
lyzed by a trehalase. Alternatively, under low osmolar-
ity conditions in E. coli, trehalose is converted to 
trehalose-6-phosphate which is then taken up by 
a trehalose-specific enzyme II (TreB) of the phospho-
transferase system [10,14]. The trehalose-6-phosphate 
is subsequently hydrolyzed to glucose and glucose- 
6-phosphate by TreC. The encoding treB and treC 
genes form an operon (the tre operon) including treR 
which encodes a regulator of the operon [14]. The 
expression of treB and treC is induced by trehalose- 
6-phosphate and repressed by TreR [15].
The nomenclature of the genes involved in trehalose 
hydrolysis is rather confusing and gene names describ-
ing the biological activity and cellular locations of pro-
teins involved are not used consistently. In E. coli there 
are at least three enzymes involved in trehalose hydro-
lysis. TreA is a trehalase found in the periplasmic space, 
hydrolyzing trehalose to glucose under conditions of 
high osmolarity [16,17], and the glucose generated can 
then be imported by the PTS [17]. An isoform of the 
TreA trehalase, termed TreF [17], is reported to be in 
the cytoplasmic compartment and also appears to play 
a key role in the degradation of trehalose synthesized 
within the bacterial cell under conditions of high osmo-
larity [16]. In some bacteria, these enzymes are called 
TreH, which is the nomenclature normally used for 
eukaryotic trehalases capable of hydrolyzing trehalose 
to glucose [18].
In the prototypic Gram-positive bacterium Bacillus 
subtilis trehalose-6-phosphate is hydrolyzed by TreA, 
a protein with sequence homology to the E. coli TreC 
enzyme [19]. TreA forms part of an operon with the 
TreP, an enzyme that phosphorylates of trehalose to 
trehalose-6-phosphate to import into the bacterial cell. 
The operon is repressed by TreR [20]. Overall, this 
operon in B. subtilis shows organizational, functional, 
and sequence similarity with the tre operon of E. coli.
Many other bacterial species possess an operon simi-
lar to the tre operons in E. coli and in B. subtilis, and 
expression of the genes within these operons is 
reported to be upregulated by trehalose [20–22]. 
However, there are important differences in the regula-
tion of these operons. For example, Streptococcus 
mutans TreR activates the operon [21] whereas the 
corresponding proteins in E. coli and B. subtilis are 
repressors [15,20].
Trehalose lipids
Trehalose lipids are found in the cell wall of some 
bacterial species, but are best studied in the 
Mycobacteria. In M. tuberculosis a range of glycolipids, 
which are derived from trehalose have been reported 
including sulfolipids [23,24], diacyltrehaloses, triacyl-
trehaloses and polyacyltrehaloses [24], trehalose 6,6 
mycolate (TMM) and trehalose 6,6 dimycolate (TDM) 
and lipooligosacharides [24]. Trehalose is converted 
into TMM by a polyketide synthase (Pks13) and sub-
sequently exported into the periplasm by mycobacterial 
membrane protein large 3 (MmpL3) [25]. The Ag85 
complex (Ag85s) facilitates TDM biosynthesis from 
TMM [25]. Trehalose can also serve as a substrate in 
the GlgE pathway which converts trehalose into α- 
glucans using four enzymes TreS, Mak, GlgE, and 
GlgB [26]. This pathway is believed to play a role in 
the synthesis of cell wall components such as capsular 
α-glucan and methyl glucose lipopolysaccharides 
[24,25]. Many of these trehalose lipids, and the 
Figure 1. Trehalose biosynthesis (black arrows), trehalose 
degradation (white arrows) and α-glucan biosynthesis (gray 
arrow) pathways in bacteria. Enzymes are shown in gray shaded 
boxes.
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pathways using trehalose as a substrate, play roles in 
virulence [24,27]. They are targets for anti- 
mycobacterial drugs (see below).
TDM (or cord factor) is the best known example of 
a trehalose lipid in M. tuberculosis [24]. Similar glyco-
lipids are found in the cell walls of other Mycobacteria, 
Nocardia, and Corynebacteria species [28]. It is synthe-
sized by the esterification of trehalose to two mycolic 
acid residues (Figure 2). The lengths of the fatty acid 
chains differ between species to species, but are typi-
cally 40–60 carbons in Nocardia and Corynebacteria 
and 70–90 carbons in the Mycobacteria [29,30]. The 
presence of TDM in the cell wall promotes the inhibi-
tion of fusion between bacteria and phospholipid vesi-
cles, such as phagosomes and lysosomes, in the host cell 
[29]. TDM is also partly responsible for the low perme-
ability of the mycobacterial cell wall, which conse-
quently confers drug resistance [30]. Recently, the 
trehalose phospholipids 6,6,-diphosphatidyltrehalose 
(diPT) and 6-phosphatidyltrehalose (PT) have been 
discovered in a group of related gram-negative bacteria 
which includes some Salmonella and Escherichiaisolates 
[31]. Like TDM, diPT is a symmetrical molecule with 
a trehalose core and lipids attached at the 6-positions, 
and it is a ligand for macrophage inducible Ca2- 
dependent lectin receptor (Mincle) [31]. However, the 
roles of diPT and PT in disease are yet to be 
determined.
Role of trehalose in protection against stress
Trehalose can play a key role in protecting bacteria, 
against a range of stresses. One of the earliest known 
examples is the observation that increasing levels of 
trehalose in spores of Streptomyces griseus provide 
increasing levels of resistance to heat and dessication 
stress [32], and this likely contributes to the ability of 
actinomycete spores to withstand harsh environmental 
conditions. High levels of accumulated trehalose also 
delayed the germination of spores, though the signifi-
cance of this is not clear. Since then, trehalose has been 
shown to also protect bacterial vegetative cells from 
a range of abiotic stresses. An E. coli mutant unable 
to produce trehalose survived poorly at 4°C compared 
to wild type bacteria [12]. Transformation with the 
otsA/otsB genes restored the ability of the bacteria to 
synthesize trehalose and resistance to cold stress [12]. 
Resistance to heat stress has been demonstrated in 
a number of bacteria and trehalose biosynthesis (ots) 
mutants of Acinetobacter baumanii [33] E.coli [34], 
Salmonella enterica [35], and Rhizobium etli [36] 
showed increased susceptibility to heat stress. 
Conversely, trehalose degradation (treA) mutants 
ofListeria monocytogenes [37] and Burkholderia pseudo-
mallei [38] showed increased resistance to heat (and 
other) stress, as a consequence of the elevated levels of 
trehalose within bacterial cells. Endogenously produced 
trehalose can also protect a range of bacterial vegetative 
cells against desiccation stress [11,39,40]. TDM might 
perform a similar function in M. tuberculosis by pro-
tecting membranes from damage caused by desiccation 
[41]. Trehalose is rarely reported to protect bacteria 
against oxidative stress, even though this is 
a commonly reported function in fungi [4]. 
Disruption of trehalose biosynthesis in Xanthomonas 
citri reduced resistance of the bacteria to H2O2 oxida-
tive stress [42]. However, in many bacteria inactivation 
of trehalose biosynthesis pathways did not decrease 
resistance to oxidative stress (Table 1). Rather, the 
reverse situation has been reported in B. pseudomallei, 
where a trehalase (treA) mutant showed increased sen-
sitivity to oxidative stress, even though the elevated 
trehalose levels in the mutant would be expected to 
protect against this stress [38]. In S. mutanstreR 
appears to play a role in resistance to oxidative stress 
including exposure to H2O2, but treA or treB mutants 
do not show a similar phenotype [21]. This suggests 
that genes outside of the trehalose operon, which are 
regulated by treR, are involved in resistance to oxidative 
stress, although the identity of the genes involved are 
not known [21]. In summary, the evidence is that 
trehalose rarely plays a role in protection against oxi-
dative stress in bacteria.
The power of trehalose to protect against abiotic 
stresses lies in the ability of this sugar to limit damage 
to biological molecules, and this is believed to be 
a consequence of several mechanisms acting together 
[1,2]. Trehalose is chemically stable and the 1,1 gly-
cosidic linkage provides conformational rigidity ren-
dering its resistance to hydrolysis. However, this is 
not the key feature which distinguishes this sugar 
Figure 2. Structures of a) TDM (cord factor) and b) TDB, a low 
toxicity derivative of TDM which has been evaluated as 
a vaccine adjuvant.[62]
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from other disaccharides. A trehalose glass can form 
around biological molecules and would be stable at 
high temperatures and when desiccated. This glass 
can form at typical environmental or mammalian 
body temperatures and could physically entrap biolo-
gical molecules [43]. At these temperatures, trehalose 
can also exist in different crystalline forms that entrap 
water [43]. The ability to transition between these 
different forms whilst retaining its structural proper-
ties, especially at the temperatures of biological sys-
tems, might be an important feature that 
distinguishes this sugar from other disaccharides 
[43]. The protective potential of trehalose also 
appears to lie with the ability of the molecule to 
preferentially form bonds with water molecules i.e. 
the bond between trehalose and water is stronger 
than the water:water bond. Whilst other disaccharides 
are also able to displace water, the hydration number 
for trehalose is higher. The conformational stability of 
trehalose provides a stable hydration shell and allows 
the molecule to both make and break water bonds [2]. 
Therefore, trehalose can displace water molecules that 
would normally be hydrogen bonded to the biological 
molecule and a hydration shell is organized around 
the trehalose molecules in the solvation layer [2,43].
Finally, it is believed that trehalose can protect 
proteins and unsaturated fatty acids from oxidative 
damage and the efficiency of this also distinguishes 
trehalose from other disaccharides [2]. Trehalose is 
able to interact with fatty acids possessing cis double 
bonds, preventing oxidative damage and the formation 
of hydroperoxides [2]. It is proposed that similar 
interactions of trehalose with cis double bonds of the 
aromatic side chains of some amino acids could pre-
vent protein aggregation [2]. Protein stabilization may 
also be associated with the role of trehalose in limiting 
Nε-lysine acetylation of proteins which would other-
wise result in increased protein hydrophobicity and 
aggregation [44]. Nε-lysine acetylation of proteins 
may be a consequence of carbon overflow within the 
bacterial cell. Therefore, in this case trehalose can 
function both as a chemical chaperone andas 
a metabolite that limits carbon overflow in biological 
systems [44].
The ability of trehalose to protect bacterial cells 
from a range of stresses might explain the role of this 
sugar in the survival of bacteria both inside and outside 
of a host. This seems to be especially true for bacterial 
pathogens of plants. For example, in Rhizobium legu-
minosarum [11], Sinorhizobium meliloti [45] and 
Bradyrhizobium japonicum [46], the ability of trehalose 
to protect against abiotic stresses has been associated 
with enhanced colonization of plant root nodules, pos-
sibly by providing increased resistance to osmotic 
stress in plant tissues [46]. Ralstonia solanacearum is 
a major cause of bacterial wilt disease and mutants 
with compromised trehalose biosynthesis show 
reduced abilities to colonize tomato plants and to 
cause disease in soil-soak infection studies. These 
mutants also show reduced resistance to osmotic stress, 
but not to other in vitrostresses. This might reflect the 
role of trehalose in promoting survival in the xylem sap 
where osmotic strength might vary depending on sugar 
levels [47]. Interestingly, during infection, the elevated 
level of trehalose found in the xylem is believed to be of 
plant rather than bacterial origin. This might also 





A. baumannii otsB Mutant grew more slowly than wild type at 40°C at 50 mM NaCl. Wild type, but not mutant, grew at 45°C [33].
E. coli otsA mutant survived poorly at 4°C for 5 days (10% survival) compared to wild type (25%) or otsBA over-expressing strain 
(>50%)[12]






Both mutants show increased susceptibility to osmotic stress (0.15 M NaCl or 15% polyethylene glycol 400). No 
difference in resistance to high (47°C) or low (20°C) temperature stress, dessication, oxidative stress[47].




otsATreY Wild type cells survived 100-fold more than mutant cells after dessication for 6 weeks[11]
Salmonella enterica otsA Reduced survival of mutant, compared to wild type, at 50°C[35]




B. pseudomallei treA Increased survival of mutant, compared to wild type, at 4°C or 65°C. Decreased survival when exposed to 40 mM tert- 




treA Compared to wild type the mutant showed increased survival at 52°C and in 20% NaCl and dessication. There were no 
reported differences in susceptibilities to 18% ethanol, 0.1% H2O2, pH 3.5 or 4°C 
[37]
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contribute to osmotic stress encountered by the 
bacteria.
Colonization of the host
There are a number of examples of trehalose playing 
a role in the colonization of plants by bacterial patho-
gens. As highlighted above, in some cases this may 
reflect the role of trehalose in protecting bacteria 
against the stresses encountered in plant tissues. The 
authors have previously found that trehalase plays 
a role in virulence of B. pseudomallei [38]. Deletion of 
the treA gene had a marked effect on growth of this 
pathogen in cell cultures and virulence in Galleria 
mellonella and in mice [38]. As highlighted above, the 
treA mutant showed a modest increase in susceptibility 
to oxidative stress, though whether this alone is suffi-
cient to explain the marked reduction in virulence is 
uncertain.
But, there is also evidence that trehalose enabling 
colonization of the host by mechanisms other than 
protecting against stresses. A potential role of the peri-
plasmic trehalase (treA) in virulence was an unexpected 
finding from a study to identify transposon mutants in 
extra-intestinal pathogenic E. coli (ExPEC) that were 
defective in binding to (and invasion of) non- 
phagocytic cells [48]. Moreover, the treA mutant 
showed reduced ability to colonize the bladder in 
a murine model of urinary tract infection, and the 
wild type phenotype was restored by complementation, 
indicating that polar effects were not responsible. This 
appears to be a consequence of the reduced abundance 
of type 1 fimbriae on the bacteria cell surface. 
Interestingly, this is not the first time that trehalose 
metabolism has been linked to virulence of ExPEC 
[49]. However, the molecular mechanisms that link 
trehalose to virulence in ExPEC are not clear.
Pathogen growth
Trehalose is an important carbon source for many 
bacteria, and can support bacterial growth. The ability 
of bacteria to use trehalose as a carbon source could 
therefore explain the reported associations with viru-
lence, by enabling bacteria growth in vivo. However, 
the utilization of trehalose as a carbon source is only 
likely to be beneficial to pathogens that grow at carbon- 
limited sites, for example outside of host tissues or cells.
Clostridium difficile causes an infection in the colon 
of humans and disease is largely a consequence of the 
production of toxins, which act on the gut. Collins et al. 
[50,51] recently showed that compared to most isolates 
of C. difficile, three phylogentically distinct ribotypes 
(RT027, RT028, and RT017) have acquired the ability 
to metabolize low concentrations of trehalose. These 
ribotypes are considered to include “hypervirulent” 
strains which are associated with the emergence, 20 or 
so years ago, of C. difficile as a leading cause of noso-
comial infection. It has been suggested that the emer-
gence of RT027 and RT078 isolates is linked to the 
introduction of trehalose as a food additive in 
N. America in the early years of the 21st century. 
However, conversely trehalose had been approved for 
use as food supplement in Japan in the mid 1990’s, but 
this did not trigger the emergence of these ribotypes in 
this country.
Two distinct mechanisms explain the enhanced abil-
ity of hypervirulent strains to metabolize trehalose 
[50,51]. RT027 and RT017 strains have point mutations 
in the trehalose repressor and this mutations result in 
increased expression of the TreA trehalase, and in the 
case of RT027 strains over 500-fold increased sensitiv-
ity to trehalose is reported [50]. In contrast, RT078 
strains had acquired a cluster of genes which enabled 
growth on low concentrations of trehalose [50]. Two 
experiments using mice with humanised microbiota 
and given trehalose orally, demonstrated the potential 
for trehalose to modulate disease. First, it was shown 
that the RT027 wild type strain was more virulent than 
a treA mutant [50]. Secondly, it was shown that com-
pared to a water control, oral dosing with trehalose 
increased the risk of disease 3-fold [50]. Additionally, 
a recent study [52] has shown that feeding trehalose or 
lactotrehalose (a trehalase-resistant form of trehalose) 
did not promote growth of C. difficile CD027 in mice, 
and actually reduced the levels of markers of inflam-
mation in gut issues. It is not clear why the results of 
this study are different to the previously reported 
effects of trehalose on the potentiation of C. difficile 
disease. However, different challenge doses were used 
in these studies, and this might influence the outcomes. 
Further work is required to understand the possible 
association of trehalose with C. difficile disease.
Two other important examples of the possible asso-
ciation between trehalose and growth of pathogens in 
the gastrointestinal tract have been reported. In extra- 
intestinal avian pathogenic E. coli, deletion of genes 
involved in the uptake of trehalose reduced the ability 
of the strain to cause experimental colibacillosis in 
poultry [49]. In S. mutans, the ability to use trehalose 
as a carbon source is believed to provide the bacterium 
with a competitive advantage in the oral cavity [21]. 
However, the interpretation of both of these studies 
may be complicated by the findings that TreR also 
appears to regulate genes outside of the tre operon in 
both pathogens [21,53,54]. For example, in S. mutans 
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this may be a consequence of the TreR mediated down-
regulation of non-lantibiotic mutacins IV, V and VI 
[21], which act on other bacteria in the oral cavity.
A very different role for trehalose in pathogen 
growth has been reported in Pseudomonas aeruginosa 
infection of plants. Here, trehalose appears to enable 
the acquisition of nitrogen-containing nutrients pro-
moting growth of the bacterium in Arabidopsis thaliana 
[55]. Consequently, P. aeruginosa treYZ and treS 
mutants show 50-fold reductions in growth in 
A. thaliana leaves, and the wild type phenotype could 
be recovered by co-dosing the mutant with trehalose, 
suggesting that altered plant signaling via T6P is not the 
reason for reduced virulence [55]. Rather, it is proposed 
that the osmotic gradient generated by the bacterial 
trehalose causes efflux of solutes, including nitrogen- 
rich compounds essential for pathogen growth, from 
plant cells into the extracellular spaces colonized by the 
bacteria [55]. The treYZ and treS mutants of 
P. aeruginosa which are highly attenuated in 
A. thaliana are not attenuated in mice, mice lacking 
the cystic fibrosis transmembrane conductance regula-
tor protein, Caenorhabditis elegans, or Drosophila mel-
anogaster [55] demonstrating the host-specific roles of 
treYZ and treS in disease.
Trehalose and modulation of the host immune 
response
There are several well-documented examples of the 
modulation of host immunity in plants and in mam-
mals, which is mediated by bacterial trehalose or tre-
halose derivatives. The decreased ability of an otsA 
mutant of Xanthomonascitri to colonize citrus leaves 
might reflect the decreased resistance of the mutant to 
salt and oxidative stresses. However, a paradoxical find-
ing was that compared to wild type, infection of plants 
with this mutant resulted in the reduced expression of 
mitogen-activated protein-kinase 3 and -kinase 4, 
wrky30 transcription factor, lipoxygenase 2, and other 
pathogenesis related genes, which are all associated 
with host defense against infection responses [42]. 
The implication of this finding is that bacterial treha-
lose signals infection to the plant.
The role of TDM in virulence is best studied in 
M. tuberculosis. A remarkable property of TDM is 
that the biological activity of the molecule is dependent 
on its local environment. TDM on the cell surface 
protects bacterial cells from killing by macrophages 
because it inhibits phagosome fusion with lysosomes 
[56]. As a monolayer, for example, when TDM is pre-
sented in an oil-in-water emulsion, it is highly toxic 
[56] destroying cells in minutes upon contact [57]. 
Many of the features of tuberculosis, from pro- 
inflammatory cytokine production to cachexia and 
granuloma formation and even death, can be induced 
by TDM alone [58]. TDM may also play a key role in 
promoting the chronic inflammation associated with 
persistent infection [59] and administration of TDM 
can induce granulomas formation in mice [56]. TDM 
is recognized by multiple macrophage C-type lectin 
receptors including Mincle [57,60] and Dectin 3 [61]. 
Binding to Dectin 3 can induce Mincle expression via 
NFκB activation, potentiating the response to TDM 
[61]. TDM can also bind to the macrophage receptor 
with collagenous structure (MARCO) receptor and the 
bound TDM factor can then activate TLR2 signaling 
[58]. TDM binding results in the activation of macro-
phages and the production of inflammatory cytokines 
via the NFκB pathway [58,61] and nitric oxide genera-
tion [60]. The Mincle-dependent pathway is character-
ized by the promotion of Th1 and Th17 responses [62]. 
Mice dosed intra-tracheally with TDM show elevated 
levels of TNFα, IL-6, IL-10, IFNγ, IL-12 and IL-4 in 
lung homogenates and elevated levels of NO in 
broncho-alveolar lavage fluid [63]. However, the panel 
of cytokines produced may be dependent on the cell 
type. For example, TNFα is released from murine bone 
marrow dendritic cells, but not from human monocytes 
of dendritic cells exposed to TDM [62]. The role of the 
trehalose phospholipids diPT and PT in disease caused 
by S. enterica and E. coli has yet to be established, 
though the ability of these molecules to bind to 
Mincle suggests that they may contribute to virulence 
of these species.
Trehalose-6-phosphate accumulation limits the 
ability of M. tuberculosis to cause disease
In M. tuberculosis and Mycobacterium bovis the otsB 
gene is essential for growth in vitro and this has been 
attributed to the intracellular accumulation of treha-
lose-6-phosphate in the mutant [64,65]. The otsB gene 
also appears to be required for the establishment of 
acute, but not chronic disease in mice [64]. There are 
no reports that the accumulation of trehalose-6-phos-
phate is lethal in any other bacteria species. Other than 
in M. tuberculosis, otsB does not appear in the database 
of essential genes for any other bacterial species. 
However, the accumulation of trehalose-6-phosphate 
is lethal in C. elegansand detrimental to the growth of 
fungi such as Saccharomyces cerevisiae [66]. In 
S. cerevisiae it is believed that the growth-limiting 
effects of trehalose-6-phosphate are a consequence of 
the inhibition of hexokinase II, which is involved in the 
first steps of glycolysis [66]. It is possible that a similar 
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mechanism explains the toxicity of accumulated treha-
lose-6-phosphate in M. tuberculosis [65]. However, 
mapping of the transcriptome in trehalose-6-phos-
phate-stressed M. tuberculosis cells revealed a wide 
range of up-regulated genes, and a much smaller 
group of down-regulated genes. The extent of gene up- 
regulation in trehalose-6-phosphate-stressed cells might 
point toward global changes in the cell that increase the 
half-lives of mRNAs [64]. In support of this suggestion, 
the vapB antitoxin genes were upregulated in trehalose- 
6-phosphate-stressed cells, and this might serve to neu-
tralize the activity of VapC RNAases [64].
Trehalose metabolism pathways as a potential 
drug targets
Trehalose biosynthetic pathways play a major role in 
virulence in fungi and consequently there has been 
progress in targeting this pathway with new antifungal 
compounds. The trehalose biosynthetic pathways are 
attractive targets for antifungals because this pathway 
is absent in mammals [67,68]. For example, enzymes 
involved in trehalose-6-phosphate biosynthesis (TPS 
and TPP) play key roles in virulence traits, such as 
the ability to grow at 37°C, capsule production and 
melanin biosynthesis as well as in cell wall integrity, 
and the regulation of glycolysis [67,69]. The regulation 
of glycolysis by trehalose-6-phosphate appears to be 
mediated by the inhibition of hexokinase II [68].
In some species of fungitrehalase enzymes play roles 
in virulence, but they are generally considered to be less 
attractive targets for drug development. This is partly 
because of trehalase redundancy, and partly because 
trehalases are found in mammals [67–69]. 
Notwithstanding these concerns, validamycin is 
a trehalase inhibitor, and has activity against phyto-
pathogenic fungi [67], because of its ability to inhibit 
the cell wall acid trehalase [70]. However, it is less 
active toward human pathogenic fungi [70].
In bacteria, and with some notable exceptions, tre-
halose metabolism is generally considered to be a less 
attractive target for antimicrobials. Many bacteria pos-
sess TPS and TPP enzymes. However, with the excep-
tion of the Mycobacteria, trehalose biosynthesis 
pathways do not appear to play an important role in 
disease.For example, an otsA mutant of Salmonella 
enterica Typhimurium was reported to show no reduc-
tion in virulence in mice [35] and global mutagenesis 
studies have confirmed that otsA and otsB do not play 
roles in virulence of S. enterica in humanized mice [71]. 
In a global mutagenesis study of B. pseudomallei 
neither otsA norotsB were found to be required for 
growth or virulence [72,73]. However, interestingly 
the B. pseudomallei genome appears to possess 2 otsA 
genes (BPSL1044 and BPSL2410), and so the possibility 
that redundancy masks the roles of the individual genes 
cannot be excluded (only one of the otsA genes, 
BPSL2410, is organized into an operon with otsB). 
Therefore, the available evidence indicates that the tre-
halose biosynthesis pathway unlikely to be a good tar-
get for broad-spectrum antibacterial compounds. 
Notwithstanding these limitations, inhibitors of OtsB 
in bacteria have been reported [74]. OtsB requires 
metal ion cofactors, and EDTA is an inhibitor by che-
lating these ions. EDTA has no clinical utility as an 
antibacterial, but inhibitors with greater specificity have 
been reported. For example, trehalose 6 phosphate has 
been reported to be an inhibitor of the P. aeruginosa 
OtsB [75]. In M. smegmatis and M. tuberculosis the 
antibiotics diumycin and moenomycin can inhibit 
OtsB activity, but the doses required for 50% inhibition 
are high (50 and 100 µg/ml) and these drugs were less 
active toward the M. tuberculosis enzyme [76]. 
Recently, there has been some exciting work to devise 
inhibitors specific for OtsB of Mycobacteria which are 
based on substrate analogs. These results showed that 
6-N-phosphonamide 6 (TNP) exhibited the highest 
inhibitory activity toward the M. tuberculosis OtsB [77].
There is some interest in developing inhibitors of the 
C. difficile TreA and drugs that target the 
B. pseudomallei TreA might have clinical utility. 
Validamycin A is not active against C. difficile TreA 
[78] but trehalose derivatives, such as epimers bearing 
hydroxyl groups at the 2- and 4-positions and also 
thiotrehalose derivatives, show potential as broader 
spectrum TreA inhibitors [78]. The value of any of 
these drugs for the treatment of specific bacterial dis-
eases awaits investigation.
Apart from the trehalose metabolism pathways out-
lined above Mycobacteria additionally possess 
a number of specialized pathways with potential drug 
targets. These pathways in the M. tuberculosis have 
received attention because of the important roles that 
they play in survival and virulence [25]. Targets include 
the GlgE and maltokinase (Mak) enzymes in the GlgE 
pathway. A substrate analog of maltose-1-phosphate, 
maltose-C-phosphonate, shows promise as a lead com-
pound [79]. The Pks13 enzyme, MmpL3 transporter, 
and Ag85 complex in the TMM/TDM biosynthesis 
pathways [25,80] are also attractive targets for anti- 
mycobacterial drugs. A new class of thiophene com-
pounds have been shown to inhibit Pks13 and when 
combined isoniazid resulted in sterilizing activity [81]. 
However, possibly the most promising drug target for 
the M. tuberculosis is MmpL3. A range of MmpL3 
inhibitors have been reported and SQ109, 
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a 1,2-ethylene diamine, has been tested in clinical 
trials [25].
Trehalose and vaccine manufacture
TDM is a potent activator of macrophages and activates 
the adaptive immune response as a consequence of 
binding to Mincle [60]. TDM is found in a number of 
experimental adjuvants including as a component of 
complete Freunds and Ribi adjuvants [60]. The toxicity 
of TDM makes it unsuitable for use in humans, but 
derivatives such as trehalose 6,6,’-dibehenate (TDB), 
are being investigated as less toxic analogs (Figure 2). 
TDB is still able to bind to Mincle and activate the 
NFκB pathway via Syk-Card9–Bcl10–Malt1 signaling, 
and cytokine production [62]. Like TDM, binding of 
TDB to Mincle, involves both glucose units and one 
acyl chain [82].
Monomolecular trehalose is well established as 
a stabilizing agent for a range of biological products, 
including vaccines. The applications of trehalose as 
a stabilizing agent for macromolecules is reviewed in 
a range of previous publications [43,83]. There are 
several reports of the addition of trehalose to stabilize 
live attenuated Pasteurella multocida [84], E. coli [85], 
Francisella tularensis [86], and S. enterica [87]. The 
exploitation of the endogenous trehalose biosynthetic 
pathway to stabilize live bacterial vaccines is less well 
documented. However, two reports suggest that the 
induction of trehalose biosynthesis can have detrimen-
tal effects on the infection competence of live attenu-
ated S. entericavaccines. In one study the loss of acid 
and bile salt tolerance was reported in bacteria subse-
quently stored at room temperature [88]. Others 
reported that growth in high salt medium induced 
trehalose in live attenuated Salmonellabut resulted in 
the loss of invasion competence [89]. However, it is not 
clear whether the loss of virulence was a direct conse-
quence of trehalose induction, or a consequence of the 
altered expression of other genes under high salt con-
ditions. It is also not known whether infection compe-
tence would be reduced after immunization by other 
than the oral route.
Discussion
Trehalose is a true multifunctional molecule, and 
numerous studies over the past two decades have 
revealed the roles of trehalose in fungal diseases. In 
fungi, trehalose acts as a stress protectant [67] though 
not an osmoprotectant [4] and yeasts are generally 
unable to grow using trehalose as a carbon source [4]. 
In fungi trehalose and trehalose-6-phosphate also play 
key roles in regulating metabolism and trehalose- 
6-phosphate is an important signaling molecule [67]. 
The role of trehalose in bacterial pathogens is less 
well understood, although we can draw on work 
with fungal pathogens to illuminate our understand-
ing. In bacteria trehalose can serve as a carbon source 
and a stress protectant [4] but there is less evidence 
that trehalose or trehalose metabolites regulate meta-
bolism or act as signaling molecules. Unlike fungi, 
trehalose is an important component of the cell wall 
in some bacterial species.
It is clear that trehalose metabolism can influence 
virulence in some bacterial species, from enabling 
growth to modulating the immune response to infec-
tion. However, there are a number of important ques-
tions that are yet to be addressed and in general the 
roles of trehalose metabolism and virulence are often 
pathogen-specific making it difficult to generalize. This 
observation suggests that broad spectrum antibacterial 
drugs or therapies, which target trehalose metabolism 
are unlikely. But pathogen-specific drug development is 
promising. The role of trehalose and trehalose deriva-
tives in the regulation of metabolism and virulence is 
an area that merits further investigation.
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